1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. INTELLIA THERAPEUTICS INC
Intellia Therapeutics Inc
XNAS: NTLA

Intellia Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a rev...

Read More
13.26 -0.22 (-1.63%)
53.06% Fall from 52W High
5.8M
XNAS Volume
High vol. this week

XNAS 01 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Intellia Therapeutics Inc is on 08 May 2026 for the purpose of Intellia Therapeutics Inc First Quarter Earnings Results for 2026 See details
Durability score
Low Financial Strength
11.1 / 100
Valuation Score
Expensive Valuation
14.0 / 100
Momentum Score
Technically Neutral
48.0 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
27
1Yr Price target upside is 102%
20 analysts

8

S

13

W

4

O

0

T

SWOT Analysis

Intellia Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..